Cognizant Technology Solutions (CTSH)
(Delayed Data from NSDQ)
$77.14 USD
+0.61 (0.80%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $77.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$77.14 USD
+0.61 (0.80%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $77.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Zacks News
6 Large-Cap Technology Stocks for Momentum Investors
by Aniruddha Ganguly
We pick six technology stocks with market capital of more than $15 billion that are ideal for momentum investors.
Guidewire (GWRE) to Commence Public & Senior Notes Offerings
by Zacks Equity Research
Guidewire (GWRE) to raise $575 million in total with its equity and senior note offerings.
6 Top-Ranked Stocks That Can Make You Jeff Bezos Like Rich
by Aniruddha Ganguly
We pick six stocks that have significant growth prospects and can enhance investors' wealth like Amazon CEO Jeff Bezos.
Genpact (G) Earnings and Revenues Beat Estimates in Q4
by Zacks Equity Research
Genpact's (G) AI based platform called Genpact Cora and its recent acquisitions are proving to be beneficial for the top line.
Top Research Reports for Novartis, BP & Biogen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Novartis (NVS), BP (BP) and Biogen (BIIB).
Cognizant (CTSH) Q4 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Cognizant's (CTSH) fourth-quarter results benefits from growth across all four segments.
Cognizant (CTSH) Q4 Earnings Top Estimates, Revenues In Line
by Zacks Equity Research
Cognizant (CTSH) reported non GAAP earnings of $1.03 per share, which beat the Zacks Consensus Estimate by six cents.
Cognizant (CTSH) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Cognizant's (CTSH) fourth-quarter results are likely to benefit from domain expertise and partnerships with leading IT-firms.
25 Stocks Powering the $300B SPY ETF for 25 Years
by Sweta Killa
We have highlighted the 25 best-performing stocks in the SPY over the past 25 years.
Cognizant Scales New 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Cognizant (CTSH) hits a 52-week high driven by its ability to capitalize on the ongoing digital transition and domain expertise.
Zacks.com highlights: Raymond James Financial, Cognizant Technology Solutions, Applied Materials, Church & Dwight and Total System Services
by Zacks Equity Research
Zacks.com highlights: Raymond James Financial, Cognizant Technology Solutions, Applied Materials, Church & Dwight and Total System Services
5 Best Stocks with Impressive Sales Growth Worth Buying
by Zacks Equity Research
Among several stock-picking strategies, we chose a rational, down-to-earth investment approach - one that focuses on sales growth of a company.
Accenture (ACN) Q1 Earnings Beat Estimates, View Strong
by Zacks Equity Research
Accenture's (ACN) continued focus on innovative product roll outs, investments in enhancing digital and marketing capabilities, along with major acquisitions, drove Q1 results.
Genpact's (G) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Genpact (G) reported better-than-expected results in third-quarter 2017 backed by growth in Global Client BPO and transformation services.
Teradata (TDC) Q3 Earnings and Revenues Beat, Decline Y/Y
by Zacks Equity Research
Teradata's (TDC) business transformation to a subscription-based model affects its third-quarter 2017.
Cognizant (CTSH) Beats on Q3 Earnings, Raises '17 EPS View
by Zacks Equity Research
Cognizant's (CTSH) third-quarter results benefited from growth across all the four segments. The raised guidance for fiscal 2017 aptly reflects these growth trends.
Cognizant (CTSH) Q3 Earnings Top Estimates, Revenues In Line
by Zacks Equity Research
Cognizant reported non GAAP earnings of 98 cents per share, which beat the Zacks Consensus Estimate by three cents.
Key Predictions for Q3 Earnings Reports of FB, ANSS & CTSH
by Zacks Equity Research
Three key technology companies will report third-quarter 2017 results on Nov 1. Let's see if these maintain the trend set by the companies that have reported so far.
What's in the Cards for Cognizant (CTSH) in Q3 Earnings?
by Zacks Equity Research
Cognizant's (CTSH) third-quarter results are anticipated to benefit from the ongoing digital transition. However, rising investments may hurt the bottom line.
A Fresh Look at US Growth
by John Blank
Third quarter GPD lights the path ahead.
The Zacks Industry Rank Highlights: Synnex Corp., Cognizant and Wipro
by Zacks Equity Research
The Zacks Industry Rank Highlights: Synnex Corp., Cognizant and Wipro
Time for a Software Upgrade? Zacks Industry Rank Analysis
by John Blank
The active Info Tech niche is currently ranked #21 out of 265 industries we rank. That is in the top 8%. The YTD 2017 return is a superb +28%.
Industry Rank Analysis: Time for a Software Upgrade?
by John Blank
The active Info Tech niche is currently ranked #21 out of 265 industries. That is in the top 8%. The YTD 2017 return is a superb +28%.
Accenture (ACN) Q4 Earnings and Revenue Surpass Estimates
by Zacks Equity Research
Accenture's (ACN) sustained focus on innovative product roll outs, consistent investments in enhancing digital and marketing capabilities, along with major acquisitions are positives.
Accenture (ACN) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Though acquisitions and improving IT spending are likely to contribute significantly to Accenture's (ACN) revenues, rising investments may dent its profitability.